Three Big Questions for Stage 3 & Patient Engagement
Chilmark Research
JANUARY 17, 2014
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. Evidence for the positive impact of this data on quality, satisfaction, and in some cases cost is thin but growing.
60 
Let's personalize your content